• Press Release

Mount Sinai Boards of Trustees Announce Updated Leadership Structure

Kenneth L. Davis, MD, extends term as Chief Executive Officer of Mount Sinai Health System through the end of 2024 Dennis S. Charney, MD, extends term as Dean of the Icahn School of Medicine at Mount Sinai and President of Academic Affairs at the System through 2025 Margaret Pastuszko, MBA, Appointed President and Chief Operating Officer of the Mount Sinai Health System

  • New York, NY
  • (September 20, 2021)

The Mount Sinai Boards of Trustees today announced leadership updates that will position the Mount Sinai Health System for future challenges and opportunities. Kenneth L. Davis, MD, will continue his role as Chief Executive Officer of the Health System through the end of 2024, and will remain in a strategic advisory capacity through 2027 and Dennis S. Charney, MD, will continue in his role as Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) and President for Academic Affairs of the Health System, responsible for the overall operation of the School, until the end of 2025. Margaret Pastuszko, MBA, was appointed President and Chief Operating Officer of the Mount Sinai Health System, becoming the first woman to be named president of a large academic health system in New York.

Dr. Davis, who became President and Chief Executive Officer of The Mount Sinai Medical Center in 2003 and of the Mount Sinai Health System upon its formation in 2013, has successfully led Mount Sinai through an era of unprecedented growth and change, including the creation of the multi-hospital Health System and the transformation of care delivery. Dr. Charney, who became Dean of Icahn Mount Sinai in 2007, has built the medical school into a top-ranked national school renowned not only for its research and innovation but for the extraordinary care it delivers and the outstanding clinicians it trains. Both have led arms of the institution during unprecedented challenges related to the pandemic, empowering clinical and research teams to implement new strategies and discover new breakthroughs during this period.

As President and Chief Operating Officer of the Health System, Ms. Pastuszko will lead the operation of the Health System, including establishing, achieving, and exceeding short-and long-term objectives; maintaining the overall viability of the Health System; and directing operations and corporate services.

“We are excited to welcome Ms. Pastuszko into her new role and are gratified that Drs. Davis and Charney will continue to provide their visionary guidance, counsel, and leadership acumen,” said Richard A. Friedman and James S. Tisch, Co-Chairmen of the Boards of Trustees of the Mount Sinai Health System. “All three are extraordinary leaders and we are certain that with this executive leadership team in place, Mount Sinai will continue to thrive, to grow, and to pursue greater equity, service, and innovation remaining steadfast in our mission to provide compassionate patient care through unrivaled education, research, and outreach into the many diverse communities we serve.” 

“Ms. Pastuszko has provided exemplary leadership and unassailable strategic guidance in implementing system goals that have helped Mount Sinai to become a global leader in health care,” said Dr. Davis. “She will bring a bold vision to this role ensuring that Mount Sinai is well-positioned for the future.”

Ms. Pastuszko joined Mount Sinai in 2000 as Director of Strategic Planning and Implementation for Mount Sinai School of Medicine, and has held positions of increasing responsibility over the years involving analytics, operations, strategy, and system integration. More recently, as Executive Vice President, Chief Operating Officer, and Chief Strategy Officer, Ms. Pastuszko led the Health System’s operational response to the COVID-19 pandemic, including a dramatic expansion of surge capacity, unprecedented efforts to balance patient loads, and provision of support to the hardest-hit hospitals, as well as the vaccination drives for employees and patients. She has worked to improve access and throughput, optimize resource allocation, and advance new technologies to enhance care and operations.  


About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across eight hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2024-2025.

For more information, visit https://www.mountsinai.org or find Mount Sinai on FacebookTwitter and YouTube.